日本细胞治疗市场报告（按细胞类型、治疗类型、治疗领域、最终用户和地区）2025-2033

2024年，日本细胞治疗市场规模达3.77亿美元。展望未来， IMARC Group预计到2033年，该市场规模将达到17.636亿美元，2025-2033年期间的复合年增长率（CAGR）为17.77%。推动市场发展的因素包括患者知识水准的提高、政府支持力度的增加以及保险覆盖范围的扩大。

细胞疗法 (CT) 是指将人类细胞移植到受损的组织和细胞上，从而治疗各种疾病。这种综合疗法涵盖多种类型的细胞，例如造血干细胞 (HSC)、骨骼肌干细胞、间质干细胞、淋巴细胞、树突状细胞和胰岛细胞。其应用范围不仅限于增强免疫系统以治疗癌症，还涵盖自体免疫疾病、感染性疾病、泌尿系统疾病、关节软骨损伤、脊髓损伤、免疫系统受损以及神经系统疾病的治疗。细胞疗法在再生药物的生产中发挥着至关重要的作用，促进了旨在修復组织和器官以及恢復因衰老、疾病或损伤而受到影响的功能的创新疗法的研发和实施。

日本细胞治疗市场趋势：

日本细胞疗法市场主要受生物技术快速发展的刺激。同时，研发投入的显着增加也对市场成长起到了至关重要的作用。此外，来自政府和私人投资者的资金投入也进一步推动了细胞疗法的研究和商业化。此外，临床试验活动的扩展有助于验证细胞疗法的有效性和安全性，从而加速市场扩张。慢性疾病和退化性疾病的日益普及催生了对先进治疗方案的需求，从而推动了市场的发展。随着人口老化，针对年龄相关疾病的再生疗法的需求日益增长，从而增强了市场竞争力。此外，针对个别患者的个人化细胞疗法日益普及，也促进了市场的成长。监管机构也正在为细胞疗法的审批提供更清晰的途径，为市场带来积极的前景。竞争格局推动着细胞治疗产品的创新和多样化，而罕见疾病发病率的上升进一步推动了市场的上升趋势。

日本细胞治疗市场细分：

细胞类型洞察：

• 干细胞
  • 骨髓
  • 血
  • 脐带来源
  • 脂肪干细胞
  • 其他的
• 非干细胞

治疗类型见解：

• 自体
• 同种异体

治疗领域洞察：

• 恶性肿瘤
• 肌肉骨骼疾病
• 自体免疫疾病
• 皮肤科
• 其他的

最终用户洞察：

• 医院和诊所
• 学术和研究机构

竞争格局：

市场研究报告也对竞争格局进行了全面的分析。报告涵盖了市场结构、关键参与者定位、最佳制胜策略、竞争仪錶板和公司评估象限等竞争分析。此外，报告还提供了所有主要公司的详细资料。

本报告回答的关键问题：

• 日本细胞治疗市场迄今表现如何？未来几年将如何表现？
• COVID-19 对日本细胞治疗市场有何影响？
• 根据细胞类型，日本细胞治疗市场是如何分類的？
• 根据治疗类型，日本细胞治疗市场是如何分類的？
• 日本细胞治疗市场依治疗领域划分是怎样的？
• 根据最终用户，日本细胞治疗市场是如何分類的？
• 日本细胞治疗市场的价值链分为哪些阶段？
• 日本细胞疗法的主要驱动因素和挑战是什么？
• 日本细胞治疗市场的结构是怎么样的？主要参与者是谁？
• 日本细胞治疗市场的竞争程度如何？

本报告回答的关键问题：

• 日本细胞治疗市场迄今表现如何？未来几年将如何表现？
• COVID-19 对日本细胞治疗市场有何影响？
• 根据细胞类型，日本细胞治疗市场是如何分類的？
• 根据治疗类型，日本细胞治疗市场是如何分類的？
• 日本细胞治疗市场依治疗领域划分是怎样的？
• 根据最终用户，日本细胞治疗市场是如何分類的？
• 日本细胞治疗市场的价值链分为哪些阶段？
• 日本细胞疗法的主要驱动因素和挑战是什么？
• 日本细胞治疗市场的结构是怎么样的？主要参与者是谁？
• 日本细胞治疗市场的竞争程度如何？

目录

第一章：前言

第二章：范围与方法

• 研究目标
• 利害关係人
• 资料来源
  • 主要来源
  • 次要来源
• 市场评估
  • 自下而上的方法
  • 自上而下的方法
• 预测方法

第三章：执行摘要

第四章：日本细胞疗法市集 - 简介

• 概述
• 市场动态
• 产业趋势
• 竞争情报

第五章：日本细胞治疗市场格局

• 历史与当前市场趋势（2019-2024）
• 市场预测（2025-2033）

第六章：日本细胞治疗市场-细分：依细胞类型

• 干细胞
  • 概述
  • 市场区隔
    • 骨髓
    • 血
    • 脐带来源
    • 脂肪干细胞
    • 其他的
• 非干细胞
  • 概述

第七章：日本细胞疗法市场-分类：依疗法类型

• 自体
  • 概述
• 同种异体
  • 概述

第 8 章：日本细胞治疗市场 - 细分：依治疗领域

• 恶性肿瘤
  • 概述
• 肌肉骨骼疾病
  • 概述
• 自体免疫疾病
  • 概述
• 皮肤科
  • 概述
• 其他的

第九章：日本细胞治疗市场-细分：依最终用户

• 医院和诊所
  • 概述
• 学术和研究机构
  • 概述

第十章：日本细胞治疗市场-竞争格局

• 概述
• 市场结构
• 市场参与者定位
• 最佳获胜策略
• 竞争仪錶板
• 公司评估象限

第 11 章：关键参与者简介

• Company A
• Business Overview
• Product Portfolio
• Business Strategies
• SWOT Analysis
• Major News and Events
• Company B
• Business Overview
• Product Portfolio
• Business Strategies
• SWOT Analysis
• Major News and Events
• Company C
• Business Overview
• Product Portfolio
• Business Strategies
• SWOT Analysis
• Major News and Events
• Company D
• Business Overview
• Product Portfolio
• Business Strategies
• SWOT Analysis
• Major News and Events
• Company E
• Business Overview
• Product Portfolio
• Business Strategies
• SWOT Analysis
• Major News and Events

第 12 章：日本细胞治疗市场 - 产业分析

• 驱动因素、限制因素和机会
  • 概述
  • 驱动程式
  • 限制
  • 机会
• 波特五力分析
  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁
• 价值链分析

第 13 章：附录

Japan cell therapy market size reached USD 377.0 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 1,763.6 Million by 2033, exhibiting a growth rate (CAGR) of 17.77% during 2025-2033. Some of the factors driving the market include the increasing knowledge among patients, the rising backing from the government, and the widening scope of insurance coverage.

Cell therapy (CT) involves the transfer of human cells to address damage to tissues and cells, offering remedies for various medical conditions. This comprehensive approach includes various types of cells such as hematopoietic stem cells (HSC), skeletal muscle and mesenchymal stem cells, lymphocytes, dendritic cells, and pancreatic islet cells. Its applications go beyond strengthening the immune system for cancer treatment and also encompass the treatment of autoimmune and infectious diseases, urinary issues, joint cartilage damage, spinal cord injuries, compromised immune systems, and neurological disorders. It plays a crucial role in the production of regenerative medicines, facilitating the creation and implementation of innovative treatments aimed at the restoration of tissues and organs and the recovery of functions affected by aging, diseases, or injuries.

Japan Cell Therapy Market Trends:

The Japan cell therapy market is primarily stimulated by the rapid progressions in biotechnology. This development is complemented by a notable increase in research and development endeavors, which are playing a significant role in the market's growth. Additionally, the influx of funding from both governmental sources and private investors is further fueling the research and commercialization of cell therapy. Furthermore, the expansion of clinical trial activities serves to authenticate the effectiveness and safety of cell therapies, thereby accelerating market expansion. The escalating prevalence of chronic and degenerative diseases is creating a demand for advanced treatment options, consequently propelling the market forward. With an aging population, there is a growing necessity for regenerative therapies tailored to age-related conditions, thus fortifying the market. Moreover, the increasing popularity of personalized cell therapies tailored to individual patients is fostering the growth of the market. Regulatory agencies are also providing clearer pathways for the approval of cell therapy, fostering a positive outlook for the market. The competitive landscape is driving innovation and diversification of cell therapy products, while the escalating incidence of rare diseases is further contributing to the market's upward trajectory.

Japan Cell Therapy Market Segmentation:

Cell Type Insights:

• Stem Cell
  • Bone Marrow
  • Blood
  • Umbilical Cord-Derived
  • Adipose-Derived Stem Cell
  • Others
• Non-stem Cell

Therapy Type Insights:

• Autologous
• Allogeneic

Therapeutic Area Insights:

• Malignancies
• Musculoskeletal Disorders
• Autoimmune Disorders
• Dermatology
• Others

End User Insights:

• Hospitals and Clinics
• Academic and Research Institutes

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

• How has the Japan cell therapy market performed so far and how will it perform in the coming years?
• What has been the impact of COVID-19 on the Japan cell therapy market?
• What is the breakup of the Japan cell therapy market on the basis of cell type?
• What is the breakup of the Japan cell therapy market on the basis of therapy type?
• What is the breakup of the Japan cell therapy market on the basis of therapeutic area?
• What is the breakup of the Japan cell therapy market on the basis of end user?
• What are the various stages in the value chain of the Japan cell therapy market?
• What are the key driving factors and challenges in the Japan cell therapy?
• What is the structure of the Japan cell therapy market and who are the key players?
• What is the degree of competition in the Japan cell therapy market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Cell Therapy Market - Introduction

• 4.1 Overview
• 4.2 Market Dynamics
• 4.3 Industry Trends
• 4.4 Competitive Intelligence

5 Japan Cell Therapy Market Landscape

• 5.1 Historical and Current Market Trends (2019-2024)
• 5.2 Market Forecast (2025-2033)

6 Japan Cell Therapy Market - Breakup by Cell Type

• 6.1 Stem Cell
  • 6.1.1 Overview
  • 6.1.2 Historical and Current Market Trends (2019-2024)
  • 6.1.3 Market Segmentation
    • 6.1.3.1 Bone Marrow
    • 6.1.3.2 Blood
    • 6.1.3.3 Umbilical Cord-Derived
    • 6.1.3.4 Adipose-Derived Stem Cell
    • 6.1.3.5 Others
  • 6.1.4 Market Forecast (2025-2033)
• 6.2 Non-stem Cell
  • 6.2.1 Overview
  • 6.2.2 Historical and Current Market Trends (2019-2024)
  • 6.2.3 Market Forecast (2025-2033)

7 Japan Cell Therapy Market - Breakup by Therapy Type

• 7.1 Autologous
  • 7.1.1 Overview
  • 7.1.2 Historical and Current Market Trends (2019-2024)
  • 7.1.3 Market Forecast (2025-2033)
• 7.2 Allogeneic
  • 7.2.1 Overview
  • 7.2.2 Historical and Current Market Trends (2019-2024)
  • 7.2.3 Market Forecast (2025-2033)

8 Japan Cell Therapy Market - Breakup by Therapeutic Area

• 8.1 Malignancies
  • 8.1.1 Overview
  • 8.1.2 Historical and Current Market Trends (2019-2024)
  • 8.1.3 Market Forecast (2025-2033)
• 8.2 Musculoskeletal Disorders
  • 8.2.1 Overview
  • 8.2.2 Historical and Current Market Trends (2019-2024)
  • 8.2.3 Market Forecast (2025-2033)
• 8.3 Autoimmune Disorders
  • 8.3.1 Overview
  • 8.3.2 Historical and Current Market Trends (2019-2024)
  • 8.3.3 Market Forecast (2025-2033)
• 8.4 Dermatology
  • 8.4.1 Overview
  • 8.4.2 Historical and Current Market Trends (2019-2024)
  • 8.4.3 Market Forecast (2025-2033)
• 8.5 Others
  • 8.5.1 Historical and Current Market Trends (2019-2024)
  • 8.5.2 Market Forecast (2025-2033)

9 Japan Cell Therapy Market - Breakup by End User

• 9.1 Hospitals and Clinics
  • 9.1.1 Overview
  • 9.1.2 Historical and Current Market Trends (2019-2024)
  • 9.1.3 Market Forecast (2025-2033)
• 9.2 Academic and Research Institutes
  • 9.2.1 Overview
  • 9.2.2 Historical and Current Market Trends (2019-2024)
  • 9.2.3 Market Forecast (2025-2033)

10 Japan Cell Therapy Market - Competitive Landscape

• 10.1 Overview
• 10.2 Market Structure
• 10.3 Market Player Positioning
• 10.4 Top Winning Strategies
• 10.5 Competitive Dashboard
• 10.6 Company Evaluation Quadrant

11 Profiles of Key Players

• 11.1 Company A
  • 11.1.1 Business Overview
  • 11.1.2 Product Portfolio
  • 11.1.3 Business Strategies
  • 11.1.4 SWOT Analysis
  • 11.1.5 Major News and Events
• 11.2 Company B
  • 11.2.1 Business Overview
  • 11.2.2 Product Portfolio
  • 11.2.3 Business Strategies
  • 11.2.4 SWOT Analysis
  • 11.2.5 Major News and Events
• 11.3 Company C
  • 11.3.1 Business Overview
  • 11.3.2 Product Portfolio
  • 11.3.3 Business Strategies
  • 11.3.4 SWOT Analysis
  • 11.3.5 Major News and Events
• 11.4 Company D
  • 11.4.1 Business Overview
  • 11.4.2 Product Portfolio
  • 11.4.3 Business Strategies
  • 11.4.4 SWOT Analysis
  • 11.4.5 Major News and Events
• 11.5 Company E
  • 11.5.1 Business Overview
  • 11.5.2 Product Portfolio
  • 11.5.3 Business Strategies
  • 11.5.4 SWOT Analysis
  • 11.5.5 Major News and Events

12 Japan Cell Therapy Market - Industry Analysis

• 12.1 Drivers, Restraints, and Opportunities
  • 12.1.1 Overview
  • 12.1.2 Drivers
  • 12.1.3 Restraints
  • 12.1.4 Opportunities
• 12.2 Porters Five Forces Analysis
  • 12.2.1 Overview
  • 12.2.2 Bargaining Power of Buyers
  • 12.2.3 Bargaining Power of Suppliers
  • 12.2.4 Degree of Competition
  • 12.2.5 Threat of New Entrants
  • 12.2.6 Threat of Substitutes
• 12.3 Value Chain Analysis

13 Appendix